retatrutide side effects trial results Lilly orforglipron oral GLP-1 phase 3 weight loss What caught my attention wasn't

This dual approval underscores the drugs effectiveness and safety profile

Increasing the dose from this adapted state is far more comfortable than hitting the body with full triple activation on day one

The triple-receptor approach appears to produce more significant results than single-target medications in some individuals

Alcohol Several studies investigating exendin-4, liraglutide, dulaglutide and semaglutide in rats and mice found a decrease in alcohol use, which was mediated by mesolimbic dopamine pathways involving the nucleus accumbens, the ventral tegmental area and the ventral hippocampus, the dorso-lateral septum, and the nucleus of the solitary tract 59,60,61,63,64,65,66,67,68,69,72,74,75,76,77,79,80,81,82,106